Medtronic, a medical technology company, has recorded revenues of $3.71 billion in the first quarter of fiscal 2009, a 19% increase over the $3.13 billion reported in the first quarter of fiscal 2008.
Subscribe to our email newsletter
Net earnings for the first quarter of fiscal year 2009 were $747 million, or $0.66 per diluted share, an increase of 11% and 12%, respectively, over the same period in the prior year.
Revenue in the cardiovascular, neuromodulation and surgical technologies product lines each grew more than 15% in the first quarter. Revenue outside the US of $1.46 billion grew 24% led by the diabetes, spinal and surgical technologies businesses. Revenue outside the US accounted for 39% of Medtronic’s revenue in the first quarter of fiscal 2009.
Bill Hawkins, CEO of Medtronic, said: In addition to the strong revenue growth driven by our diversified product portfolio, we were pleased to see continued progress in our efforts to deliver operating leverage as demonstrated by a 25% increase in operating income.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.